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Abstract Senescence is a stable proliferation arrest charac-
terized by profound changes in cellular morphology and me-
tabolism as well as by extensive chromatin reorganization in
the nucleus. One particular hallmark of chromatin changes
during senescence is the formation of punctate DNA foci in
DAPI-stained senescent cells that have been called
senescence-associated heterochromatin foci (SAHF). While
many advances have been made concerning our understand-
ing of the effectors of senescence, how chromatin is
reorganized and maintained in senescent cells has remained
largely elusive. Because chromatin structure is inherently
dynamic, senescent cells face the challenge of developing
chromatin maintenance mechanisms in the absence of DNA
replication in order tomaintain the senescent phenotype. Here,
we summarize and review recent findings shedding light on
SAHF composition and formation via spatial repositioning of
chromatin, with a specific focus on the role of lamin B1 for
this process. In addition, we discuss the physiological impli-
cation of SAHF formation, the role of histone variants, and
histone chaperones during senescence and also elaborate on
the more general changes observed in the epigenome of the
senescent cells.
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Abbreviations
ATRX Alpha-thalassemia/mental retardation X-linked
DAXX Death-domain associated protein
HP1 Heterochromatin protein 1
H3K9me3 Histone H3 trimethylated at lysine 9
OIS Oncogene-induced senescence
PML Promyelocytic leukemia
PML-NBs PML nuclear bodies
SAHF Senescence-associated heterochromatin foci
Introduction
Cellular senescence is a stable proliferation arrest that can be
triggered by telomere shortening or by oxidative, genotoxic,
and other cellular stresses (Rai and Adams 2011). In addition,
overexpression of activated oncogenes such as H-RasV12
induces a DNA damage response that ultimately leads to
oncogene-induced senescence (OIS) that can act as an anti-
cancer barrier (Serrano et al. 1997; Bartkova et al. 2006; Di
Micco et al. 2006; Mallette et al. 2007). Senescence has thus
emerged as an important tumor-suppressing mechanism to
prevent further proliferation of premalignant cells and may
also be implicated in tissue and organ aging (Rodier and
Campisi 2011). However, the prevailing view of senescence
occurring only under pathological conditions has now been
challenged by the discovery that cellular senescence has an
important physiological role during development. Senescent
cells were identified during mammalian embryonic develop-
ment at multiple locations, and their clearance by macro-
phages contributes to tissue remodeling and patterning of the
embryo (Muñoz-Espín et al. 2013; Storer et al. 2013). Cellular
senescence may thus have originated in evolution as a crucial
part of normal development and may have been further
adopted as a mechanism to eliminate dangerous cells.
Despite being arrested, senescent cells are characterized by
an altered physical flat and enlarged morphology and are
metabolically active. A hallmark feature of senescent cells is
a modified transcriptional program characterized by the prom-
inent secretion of a complex mixture of extracellular matrix
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and soluble factors. This feature—referred to as the
senescence-associated secretory phenotype (SASP) (Coppe
et al. 2008)—participates in the reinforcement of the arrested
state (Acosta et al. 2008; Kuilman et al. 2008). Senescent cells
also display senescence-associated β-galactosidase (SA-β-
Gal) activity as a consequence of an increased number of
lysosomes (Dimri et al. 1995; Kurz et al. 2000). In addition,
one striking characteristic of senescent cells is the large-scale
reorganization of their chromatin. The basic unit of chromatin,
the nucleosome core particle, comprises 147 base pairs of
DNA wrapped around a core histone octamer, containing
two times each of the core histones (H2A, H2B, H3, and
H4). The linker histone H1 and nonhistone proteins participate
in the dynamic regulation of chromatin compaction within the
nucleus. Upon senescence entry, chromatin structure is exten-
sively remodeled as exemplified by the formation of
senescence-associated heterochromatin foci (SAHF), visible
as microscopically discernible, punctate DNA foci in DAPI-
stained senescent cells (Narita et al. 2003; Zhang et al. 2005).
While the network of effector pathways contributing to the
senescence phenotype, for example, the prominent roles of the
pRb and p53 pathways, has been described in detail in recent
years (for review, Funayama and Ishikawa 2007; Rai and
Adams 2011; O’Sullivan and Karlseder 2012), little is known
about the underlying mechanisms of the extensive chromatin
reorganization observed in senescent cells. In addition, how
senescent cells (which can persist in the human body for
decades as exemplified by senescent melanocytes in benign
human nevi (Michaloglou et al. 2005)) face the challenge of
chromatin maintenance in the absence of proliferation has
remained unclear.
In this review, we discuss recent data that have increased
our knowledge about how chromatin is reorganized and main-
tained during senescence, which is essential for genome sta-
bility. Specifically, we focus on SAHF formation and function
in senescence and highlight novel contributions of lamin B1 in
chromatin reorganization. We discuss the dynamics of histone
variants and histone chaperones in senescence, as well as
changes in the epigenome of senescent cells.
Chromatin reorganization and structure of SAHF
SAHF, as initially described by Narita and colleagues, are
visible as punctate DNA foci upon DAPI staining of senescent
human primary fibroblats (Narita et al. 2003) (Fig. 1a). These
foci are enriched in heterochromatic markers such as histone
H3 trimethylated at lysine 9 (H3K9me3), heterochromatin
protein 1 (HP1), and histone macroH2A (Narita et al. 2003;
Zhang et al. 2005), a histone variant associated with gene
silencing, for example, during X inactivation (Costanzi and
Pehrson 1998). Typical euchromatic histone marks such as
H3K4me3 or H3K9ac, as well as RNA polymerase II, are
excluded from SAHF (Narita et al. 2003; Funayama et al.
2006). As a consequence, SAHF are thought to represent
transcriptionally inactive regions which is further supported
by the lack of any nascent RNA signals in these structures
(Narita et al. 2003; Funayama et al. 2006; Corpet et al. 2014)
(Fig. 1b). In addition to H3K9me3 and HP1 enrichment in
SAHF, linker histone H1, usually considered to be a facilitator
of chromatin condensation, is unexpectedly downregulated
upon OIS and absent from SAHF (Funayama et al.
2006). In parallel, increased levels of the high mobility
group A (HMGA) proteins have been reported in SAHF
(Narita et al. 2006).
Chromosome painting analyses showed that each individ-
ual chromosome condenses into a single SAHF focus
(Funayama et al. 2006; Zhang et al. 2007a). Development of
highly specific monoclonal antibodies against various histone
marks has enabled a refined characterization of the SAHF
structure. SAHF are highly organized structures composed
of multiple chromatin types arranged in concentric layers.
The SAHF core is enriched with the constitutive heterochro-
matin mark H3K9me3 and is surrounded by an outer layer of
H3K27me3 (a facultative heterochromatin marker) thus
allowing separation of the silent core from the transcription-
ally active regions (marked with H3K36me3) (Chandra et al.
2012) (Fig. 1c). This highly structured organization supports
the idea that SAHF formation may contribute to the mainte-
nance of gene expression profile stability for both active and
repressed genes. Interestingly, the H3K9me3-enriched do-
mains of constitutive heterochromatin such as pericentromeric
and telomeric heterochromatin are not a part of SAHF but
localize to the periphery of SAHF (Narita et al. 2003; Narita
et al. 2006; Funayama et al. 2006; Zhang et al. 2007a), thus
further supporting the idea of a spatial segregation of distinct
chromatin states in senescent cells.
The incorporation of histone variants into chromatin is one
way of modulating nucleosome stability and function (Talbert
and Henikoff 2010; Luger et al. 2012) and is orchestrated by a
family of proteins called histone chaperones (Burgess and
Zhang 2013). While the histone variant H3.3 differs by only
five amino acids from the canonical replicative variant H3.1, it
has been technically challenging to address whether H3.3 is
incorporated into SAHF and this issue has remained a matter
of debate (for review, Adams 2007; Rai and Adams 2011).
Because the H3.3-specific histone chaperone histone regulator
A (HIRA) has been implicated in SAHF formation (see be-
low) (Zhang et al. 2005; Zhang et al. 2007a), H3.3 was
proposed to be enriched in SAHF. We have now addressed
this issue by using human primary diploid fibroblasts express-
ing epitope-tagged forms of the H3 variants, H3.1 and H3.3,
or by using an antibody highly specific for H3.3, which has
recently been developed.We showed that both epitope-tagged
H3.3 and endogenous H3.3 do not localize into SAHF but are
actually excluded from the DAPI-dense regions. In addition,
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H3.3 localization correlates with transcriptional activity in
senescent cells (Corpet et al. 2014). Interestingly, these results
are in line with the “active pattern of posttranslational mod-
ifications (PTMs) found on H3.3 (Hake et al. 2006; Loyola
et al. 2006) and with the fact that deposition of H3.3 is
typically associated with transcriptional activation (Ahmad
and Henikoff 2002; Chow et al. 2005; Wirbelauer 2005;
Mito et al. 2005; Jin et al. 2009). However, this does not
exclude localization of H3.3 in pericentromeric or telomeric
regions, as demonstrated in proliferating cells (Wong et al.
2008; Goldberg et al. 2010; Drane et al. 2010; Corpet et al.
2014). These regions localize outside of SAHF in senescent
cells. In contrast, new H3.1 was not deposited in senescent
cells, but the preexisting pool of H3.1 was enriched in SAHF
(Corpet et al. 2014). This is consistent with previous data
showing enrichment for heterochromatin marks on arrays of
nucleosomes containing the canonical H3.1 (Loyola et al.
2006). Moreover, these findings support the hypothesis that
a spatial rearrangement of preexisting heterochromatin upon
senescence entry is the predominant mechanism of SAHF
formation (Chandra et al. 2012; Chandra and Narita 2013)
(see also below).
Beyond the typical SAHF formation, chromatin is further
reorganized upon senescence. The thickness of the perinuclear
H3K9me3-rich heterochromatin is significantly diminished in
senescent cells (De Cecco et al. 2013; Sadaie et al. 2013). In
addition, an age-related global loss of histones H3-H4 has
been reported at the protein level both during aging of budding
yeast and in human cells that are approaching replicative
senescence (Feser et al. 2010; O’Sullivan et al. 2010). This
event is thought to promote destabilization of chromatin struc-
ture together with misregulated gene expression and triggers a
DNA damage response that enforces the aging phenotype.
Thus, these observations suggest that chromatin alterations
upon senescence might contribute to the aging process (for
review, Rodier and Campisi 2011; O’Sullivan and Karlseder
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Fig. 1 Structure and composition of SAHF. a Fluorescent microscopy
visualization of proliferating (empty) or senescent human diploid fibro-
blasts induced into senescence with H-RasV12 overexpression (Ras).
Only proliferating cells are labeled with BrdU (green). DAPI stains
chromatin and is a marker of SAHF formation visible as DAPI-dense
foci. Scale bar is 10 μm. Adapted fromCorpet et al. (2014) b Fluorescent
microscopy visualization of nascent global RNA transcription in vivo in
human diploid fibroblasts treated as in a (left). Nascent RNAs were
labeled with 5-ethynyl uridine (EU) and revealed by the Click-iT chem-
istry (red). SAHF are marked by the presence of H3K9me3 (green) and
are visible as DAPI-dense foci. Scale bar is 10 μm. Graphs, showing
fluorescent intensity profiles quantified along lines drawn through nuclei,
underscores that transcriptional activity is excluded from SAHF (right).
Adapted fromCorpet et al. (2014) cConfocal microscopy visualization of
indicated histone marks in human diploid fibroblasts induced in senes-
cence by overexpression of H-RasV12 (RIS). The region indicated by the
rectangle is magnified. The arrow indicates the path over which fluores-
cent intensity was profiled (graphic on the right). This image underscores
the highly structured chromatin organization of SAHF in concentric
layers. At the core, SAHF are enriched in H3K9me3, a mark of consti-
tutive heterochromatin. The SAHF core is encircled by a ring of
H3K27me3, a facultative heterochromatin mark. This latter ring separates
the core from transcriptionally active regions marked by H3K36me3.
Adapted from Chandra et al. (2012)
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2012). Interestingly, Ivanov et al. recently showed the appear-
ance of cytoplasmic chromatin fragments (CCFs) in late se-
nescent cells, which are processed by an autophagic/
lysosomal pathway, resulting in low histone content. This
would contribute to the stability and “deepness of the senes-
cence phenotype in mature portions of human nevi (Ivanov
et al. 2013). In the case of H3 variants, the centromeric CENP-
A (another H3 variant) is diminished in senescent cells
through transcriptional and posttranslational control mecha-
nisms (Maehara et al. 2010). In contrast, the amount of histone
H3.3 increases during replicative senescence of human fibro-
blasts concomitant with a decrease in the amount of canonical
H3.1, suggesting an important role of H3.3 during senescence
(Rogakou and Sekeri-Pataryas 1999). Intriguingly, the specif-
ic H3.3K36me3 modification that is deposited on gene bodies
during transcriptional elongation was recently implicated in
recruiting the tumor suppressor ZMYND11, thus linking the
H3.3-mediated transcriptional elongation control with tumor
suppression (Wen et al. 2014). In addition, mutations of H3.3
on G34 in pediatric brain tumors may impact on the ability of
histone-modifying complexes to methylate H3.3 K36, which
may be altering transcription of key target genes (for review,
Liu et al. 2014). Thus, whether H3.3 and its specific modifi-
cation H3.3K36me3 could contribute to senescence via main-
tenance of a specific transcriptional program remains to be
investigated. In any case, these data emphasize the novel
importance of the histone variant H3.3 in tumor suppression.
Factors involved in SAHF formation
Since the implication of the p16INK4A-Rb and p53-Rb path-
ways in SAHF formation has been extensively described and
reviewed (Serrano et al. 1997; Narita et al. 2003; Chan 2005;
Ye et al. 2007; Chicas et al. 2010) (for review, Rodier and
Campisi 2011; O’Sullivan and Karlseder 2012), we focus here
on the role of chromatin-associated components in SAHF
formation.
Role of histone chaperones and how they are linked to PML
nuclear bodies
Histone chaperones are factors that interact with histones
throughout their cellular life and play a crucial role in nucle-
osome assembly (Burgess and Zhang 2013). While the canon-
ical histone H3.1 is deposited in chromatin by chromatin
assembly factor 1 (CAF-1) in a DNA synthesis-dependent
manner, several specific histone chaperones exist for the his-
tone H3 variant H3.3 and deposit this particular protein into
chromatin in a DNA synthesis-independent manner. The his-
tone chaperone HIRA along with associated factors, anti-
silencing function 1a (ASF1a), ubinuclein 1 (UBN1), and
Cabin1, is responsible for H3.3 deposition into active
chromatin, whereas the H3.3-specific chaperone death
domain-associated protein (DAXX) in cooperation with the
chromatin remodeler α-thalassemia/mental retardation syn-
drome X-linked (ATRX) is essential for H3.3 deposition at
heterochromatic loci (for review, Burgess and Zhang 2013).
Since cellular senescence is associated with large-scale chro-
matin alterations, a long-standing question has been whether
the histone chaperones have a particular role during senes-
cence. The first clue to this question came from Adams and
colleagues who reported that ectopic overexpression of his-
tone chaperones HIRA and ASF1a leads to SAHF formation
in primary human fibroblasts (Zhang et al. 2005) and requires
the H3-binding region of ASF1 (Zhang et al. 2007a). In
addition, it was shown that knockdown of ASF1a by RNAi
impairs OIS induced by overexpression of H-RasV12 (Zhang
et al. 2005). Interestingly, HIRA localizes in promyelocytic
leukemia (PML) nuclear bodies (PML-NBs) as cells enter
senescence, and this is required for SAHF formation.
Indeed, dominant negative HIRA mutants that block HIRA’s
localization in PML-NBs prevent SAHF formation, as does
the disruption of PML-NBswith a PML-RARα fusion protein
(Zhang et al. 2005; Ye et al. 2007). PML-NBs are discrete
foci, 0.2–1.0-μm wide, that are present in most mammalian
cell nuclei. They stain positive for the tumor suppressor PML
and have been implicated in the onset of OIS (Bernardi and
Pandolfi 2007; Lallemand-Breitenbach and de The 2010).
Importantly, other members of the HIRA complex, namely
UBN1 and Cabin1, were also shown to localize to PML-NBs
only in senescent cells, and ectopic expression of these two
proteins also led to SAHF formation and senescence entry,
suggesting a function of the entire HIRA histone chaperone
complex in SAHF assembly (Banumathy et al. 2009; Rai et al.
2011). Thus, these data suggested that the H3.3 histone chap-
erones forming the HIRA complex localize to PML-NBs
during senescence and that this is important for SAHF forma-
tion (Fig. 2). In addition, HP1 proteins transiently localize to
PML-NBs prior to their incorporation into SAHF (Zhang et al.
2005) further highlighting a connection of these nuclear bod-
ies with heterochromatin assembly in senescence.
However, it is still unclear if SAHF formation is mediated
by the incorporation of H3.3 into chromatin. Functional im-
plication of H3.3 in senescence as well as the role of its other
specific chaperones DAXX and ATRX, which localize in
PML-NBs in proliferating cells (Xue et al. 2003; Ishov
2004), was recently investigated. Remarkably, DAXX,
ATRX, or H3.3 is dispensable for senescence entry, consistent
with the absence of H3.3 localization at SAHF (Corpet et al.
2014). While genome-wide incorporation of H3.3 is only
affected by HIRA but not by DAXX depletion (Ray-Gallet
et al. 2011; Corpet et al. 2014), further studies investigating
the requirement for H3.3 or HIRA in senescence maintenance
should provide more insights into the role of this variant
during senescence. Interestingly, H3.3 was found to be
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targeted to PML-NBs in a DAXX-dependent manner both in
proliferating and senescent cells (Delbarre et al. 2013; Corpet
et al. 2014) (Fig. 2). Thus, while PML-NBs play important
functions during senescence through regulation of the p53 and
Rb/E2F pathways (Pearson et al. 2000; Ferbeyre et al. 2000;
de Stanchina et al. 2004; Vernier et al. 2011; Martin et al.
2011), they may also represent novel interstages in the
replication-independent chromatin assembly pathway
(Fig. 2). However, the exact functional role of PML-NBs in
chromatin dynamics in senescence remains to be elucidated.
Concerning the loading of the macroH2A variant into
SAHF, it is interesting to note that ATRX has also been
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Fig. 2 SAHF formation and PML-NBs dynamics. In proliferating cells,
two pathways regulate H3.3 deposition into chromatin independently of
DNA synthesis. DAXX cooperates with the chromatin remodeler ATRX
for the accumulation of H3.3 at pericentric and telomeric heterochromatin
(1). Importantly, H3.3 localizes in PML-NBs in a DAXX-dependent
manner, and this is an essential process for its subsequent deposition on
pericentromeric heterochromatin. In euchromatin, the HIRA complex
(comprising HIRA, Cabin1, and UBN1) is responsible for H3.3 enrich-
ment in the body of transcribed genes and at promoters of transcribed or
nontranscribed genes (2). Whether this latter pathway requires the tran-
sient localization of the HIRA complex in PML-NBs to be loaded with
H3.3 is not clear (dashed arrow) (2a). Alternatively, the histone chaper-
one ASF1 acts directly as a histone donor for the HIRA complex (2b). In
senescent cells, PML-NBs increase in size and number. As an early event
during senescence, localization of the HIRA complex as well as ASF1 in
PML-NBs is required for SAHF formation (3). HP1 proteins also tran-
siently localize in PML-NBs before their incorporation into SAHF, but
their presence is actually not a prerequisite for SAHF formation (4). As in
proliferating cells, DAXX is required for H3.3 localization in PML-NBs.
However, whether this is important for H3.3 incorporation at
pericentromeric heterochromatin and whether the HIRA complex regu-
lates H3.3 deposition at active genes in senescence has not been investi-
gated yet. In addition, it remains unknown if ATRX, which localizes at
SAHF, can regulate incorporation of macroH2A in SAHF (5). PML-NBs
thus appear as important regulatory structures involved in chromatin
dynamics in senescent cells, but, of note, this figure does not depict the
well-established role of PML-NBs in the regulation of p53 and Rb/E2F
dynamics in senescence
Chromosoma (2014) 123:423–436 427
identified as a macroH2A chaperone (Ratnakumar et al.
2012). MacroH2A is incorporated into chromatin after the
appearance of SAHF suggesting that this variant may play a
role in the maintenance of SAHF rather than in their induction
(Zhang et al. 2005; Funayama and Ishikawa 2007). Thus, it
should be further investigated if ATRX, which localizes at
SAHF in senescent cells but is not essential for SAHF forma-
tion (Corpet et al. 2014), could contribute to SAHF mainte-
nance in senescent cells via the regulation of macroH2A
dynamics (Ratnakumar et al. 2012).
Dynamics of architectural components upon SAHF formation
Since SAHF are characterized by the presence of heterochro-
matin marks, as well as by the presence of chromatin-
associated HMGA proteins, we will discuss how these archi-
tectural components affect SAHF formation.
The specific role of H3K9me3 and HP1 in SAHF forma-
tion is still unclear. Senescent cells display an increase in the
total amount of chromatin-bound HP1 (β or γ), which binds
to H3K9me3 (Narita et al. 2003; Di Micco et al. 2011). In
addition, relative to proliferating cells, a general increase in
the resistance of nuclear chromatin to digestion by nucleases
can be observed (Narita et al. 2003). However, the total
amount of H3K9me3 does not substantially change in senes-
cent cells (Funayama et al. 2006; Chandra et al. 2012). Thus, it
is possible that the nonstoichiometric increase in the total
amount of HP1 proteins compared to H3K9me3 in senescent
cells could be explained by the association of HP1 with other
histone marks (Dawson et al. 2009) or to a change in affinity
of HP1 for H3K9me3. Interestingly, expression of a dominant
negative form of HP1β (HP1βΔN) that reduces the amount of
all three chromatin-bound isoforms of HP1 by about 80 %
does not affect SAHF formation and senescence entry (Zhang
et al. 2007b). In addition, profiling of the repressive histone
mark H3K9me3 in senescent human primary fibroblasts sur-
prisingly showed that the landscape of H3K9me3 remains
remarkably unchanged upon OIS despite normal SAHF for-
mation (Chandra et al. 2012) (see further in Fig. 4a). Thus,
although this repressive mark is locally enriched at specific
genes (Narita et al. 2003), its highly static pattern strongly
suggests a 3D repositioning of preexisting marks to form
SAHF, rather than formation and spreading of new hetero-
chromatin in SAHF (Chandra and Narita 2013). Of note,
H3K9me3 is also dispensable for SAHF formation in cells
where the H3K9me3 demethylase JMJD2D is overexpressed
(Chandra et al. 2012). Thus, these data suggest that HP1 and
H3K9me3, hallmarks of constitutive heterochromatin, are
dispensable for the formation of the highly compacted
SAHF core. While other repressive histone marks might be
involved in this process, chromatin proteins that do not require
binding to histones may also contribute to SAHF formation.
In particular, one structural component of SAHF, the archi-
tectural protein HMGA1, an “AT-hook containing protein
that binds the minor groove of AT-rich DNA, is required for
both the establishment and maintenance of SAHFs as shown
by ectopic overexpression and knockdown experiments
(Narita et al. 2006). This was unexpected because HMGA
proteins are known to favor transcriptionally active chromatin
and promote tumor progression (Reeves 2001; Hock et al.
2007). Interestingly, another AT-hook DNA-binding protein
has been associated with repressive chromatin independently
of heterochromatic histone marks in Drosophila (Filion et al.
2010). Thus, HMGA proteins may contribute to SAHF for-
mation by bending linker DNA and thus promote chromatin
condensation (Funayama and Ishikawa 2007). In parallel, it
was shown that histone H1 is absent from chromatin and from
the entire cell upon senescence entry and that its loss is
correlated with frequency of SAHF formation (Funayama
et al. 2006; Funayama and Ishikawa 2007). Since histone
H1 and HMGA proteins compete for the same binding site
on DNA, this suggests that histone H1 could be substituted
with HMGA proteins on chromatin in senescent cells (Catez
et al. 2004). In summary, while the role of HMGA proteins
seems to be essential in SAHF formation, the role of HP1 and
H3K9me3 remains to be further analyzed. Investigating the
role of histone H3K9me3 methylases/demethylases should
help to determine the importance of this modification in
senescence.
The role of the nuclear lamina in histone PTM dynamics
and SAHF formation
The nuclear lamina (NL) forms a scaffold of lamin proteins
underneath the inner nuclear membrane. Beyond this struc-
tural role, interaction of the NL with the genome suggests that
the lamina plays a role in organizing chromatin into domains
marked by distinct epigenetic modifications that are widely
involved in the control of gene expression programs during
lineage commitment and terminal differentiation (Peric-
Hupkes et al. 2010) (for review, Burke and Stewart 2013;
Bickmore and van Steensel 2013). In particular, genome-
wide mapping of lamin B1 (LMNB1) identified large
lamina-associated domains (LADs), forming a repressive en-
vironment in which the majority of genes are transcriptionally
inactive and enriched with repressive histone marks (Guelen
et al. 2008; Bickmore and van Steensel 2013) (Fig. 3).While it
was previously known that global LMNB1 levels are down-
regulated during senescence (Shimi et al. 2011; Freund et al.
2012), LMNB1 alterations have now been mechanistically
linked to the large-scale changes in chromatin organization
and gene expression (Sadaie et al. 2013; Shah et al. 2013).
Using ChIP-Seq to map the genomic binding profiles of
LMNB1 in primary human fibroblasts, an uneven redistribu-
tion of LMNB1 genomic binding upon senescence, with a
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more pronounced reduction of LMNB1 in H3K9me3 regions,
at the center of LADs, was observed (Sadaie et al. 2013)
(Fig. 3). Interestingly, small hairpin RNA (shRNA)-mediated
LMNB1 reduction induced a mild senescence phenotype
(Sadaie et al. 2013; Shah et al. 2013) associated with moderate
SAHF formation, which was increased by combined overex-
pression of HMGA proteins (Sadaie et al. 2013). This sug-
gests that LMNB1 reduction during senescence facilitates
repositioning of H3K9me3-rich heterochromatin toward the
nuclear center, and this could help SAHF formation (Fig. 3).
In addition, changes in the nuclear lamin interactions with
the genome have now been linked to histone PTM changes
upon senescence. Shah et al. mapped the histone H3K4me3
and H3K27me3 modifications in replicative senescent human
fibroblasts and found that the global levels of these marks do
not change upon senescence (Shah et al. 2013). However,
genome-wide altered patterns of these modifications were
observed. Specifically, H3K4me3 was enriched in large do-
mains of a few hundreds of kilobases (called “mesas ),
overlapping with large domains of enrichment of
H3K27me3 and with LADs (Shah et al. 2013). In addition,
large domains of reduced H3K27me3 modification were also
observed (called “canyons ), corresponding to transcriptional
enhancer regions (Fig. 4a). Interestingly, shRNA-mediated
LMNB1 depletion triggered these pattern alterations of
H3K4me3 and H3K27me3 during senescence (Shah et al.
2013). This suggests that loss of LMNB1 could facilitate the
genome-wide local changes of H3K4me3 and H3K27me3
with an enrichment of these modifications at the center of
LADs.
Importantly, genome-wide studies revealed that alterations
in LMNB1 and histone PTMs patterns are also linked to the
regulation of gene expression thus suggesting that these may
be important effectors of senescence. Indeed, H3K4me3 de-
pletion is correlated with downregulation of cell cycle and
proliferating genes (Shah et al. 2013). In addition, H3K27me3
loss (a repressive mark) is strongly correlating with upregula-
tion of a number of genes involved in senescence entry and
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Fig. 3 Model for the role of lamin B1 (LMNB1) in SAHF formation. In
proliferating cells, LMNB1 forms a filamentous structure beneath the
inner nuclear membrane (INM), which is implicated in the integrity of
nuclear structure and regulation of gene expression. In particular, lamina-
associated domains (LADs) form a repressive environment in which the
majority of genes are transcriptionally inactive and enriched with repres-
sive histone marks such as H3K9me2/3 and H3K27me3. In senescent
cells, three mechanisms affecting LMNB1 could potentially contribute to
the senescent phenotype: (1) LMNB1 levels are globally downregulated
in senescence, and this is associated with reduced cell proliferation (Shimi
et al. 2011; Barascu et al. 2012). (2) Loss of LMNB1 binding
preferentially from H3K9me3 rich-regions at the center of LADs partic-
ipates in the spatial repositioning of heterochromatin (H3K9me3-
enriched), and this would help SAHF formation (Sadaie et al. 2013). In
addition, LMNB1 loss would also contribute to establishment of the
changes observed in histone PTMs upon senescence (Shah et al. 2013).
(3) In about 2 % of the genome, LMNB1 shows an increased binding,
together with increased H3K27me3 across the gene bodies. Genes within
these regions tend to be repressed and include cell cycle genes. Thus,
LMNB1 could participate in gene regulation, and this could help to
reinforce the proliferation arrest
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Fig. 4 Altered epigenome in senescent cells. This figure presents
a model for how the altered epigenome in senescent cells may
contribute to the senescent phenotype. a Altered chromatin and
histone PTMs in senescence. (1) Genome-wide mapping of open
chromatin regions by the formaldehyde-assisted isolation of reg-
ulatory elements (FAIRE) method identified two processes: a
“closing of gene-rich, H3K4me3-rich, early-replicating regions,
and a paradoxical “opening of heterochromatin regions, which
is associated with expression of transposable elements and satel-
lite DNA as described in 4. (2) Schematic view of the genome-
wide mapping of specific histone PTMs via ChIP-Seq. Several
independent processes were identified: for H3K9me3, the land-
scape remains globally unchanged and this underscores the spatial
reposit ioning of heterochromatin upon senescence. For
H3K27me3, another repressive mark, the situation is less clear
(Sadaie et al. 2013; Shah et al. 2013). Nevertheless, Shah et al.
identified some large regions of gains and losses that correlate
with the repression of cell cycle genes or the upregulation of key
senescence genes such as SASP genes, respectively. In addition,
regions of H3K27me3 gains also correlate with increased
H3K4me3 and LAD regions. Thus, large-scale changes in histone
PTMs might contribute to the senescent phenotype by regulating
gene expression. b Altered methylation in senescent cells. (3)
Local hypermethylation at CpG islands can contribute to the
repression of cell cycle genes, and this would reinforce the
senescence-associated proliferation arrest. (4) On the other hand,
global hypomethylation at gene-poor, late-replicating, or LAD
regions would increase transcription of satellite DNA and trans-
posable elements. The physiological relevance of this process
remains to be fully understood, but the increased RNA transcrip-
tion of satellite DNA could hypothetically contribute to the se-
nescent phenotype by reinforcing heterochromatinization of these
regions. In any case, the significant overlap of methylation
changes with those observed in cancer cells suggests that some
features of the cancer methylome could originate from a prema-
lignant senescent state that has been overcome
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maintenance such as the key SASP genes (Shah et al. 2013).
In contrast, local increase of the H3K27me3 modification
associated with LMNB1 binding in a subset of gene-rich
regions facilitates the repression of genes belonging to the cell
cycle Gene Ontology category during senescence (Sadaie
et al. 2013) (Fig. 4a). In conclusion, these studies have helped
to further our understanding of the dynamic changes in chro-
matin structure upon senescence. They shed new light on the
functional role of lamins as effectors of senescence through
their ability to regulate spatial chromatin reorganization and
hence, gene expression. However, some conflicting observa-
tions upon overexpression of LMNB1 still need to be re-
solved. Two studies reported increased senescence upon over-
expression of LMNB1 (Barascu et al. 2012; Dreesen et al.
2013), while others found delayed senescence (Shimi et al.
2011; Sadaie et al. 2013; Shah et al. 2013) (for review, Burke
and Stewart 2013).
These studies revealed the importance of changes of his-
tone PTMs in senescence and the role of the nuclear lamina in
this process, but it is important to note that changes in histone-
modifying enzymes have also been implicated in senescence
(for review, David 2012). For example, knockdown of the
H3K27me3 methylase EZH2 leads to rapid senescence in
primary human cells, consistent with the dispensable role of
H3K27me3 for SAHF formation (Chandra et al. 2012). This
process could be mediated in part by upregulation of
p16INK4A (Bracken et al. 2007). It remains to be determined
to which extent these histone modifiers affect senescence at
the level of transcriptional regulation of specific genes or
genome-wide in the context of chromatin reorganization.
Global epigenetic changes in senescent cells resemble
epigenetic alterations in cancer
While we have discussed chromatin changes occurring in
senescence at the levels of histone variants, histone modifica-
tions, and heterochromatin formation, it has become apparent
that global epigenetic changes such as changes in chromatin
accessibility and DNA methylation also occur in senescent
cells. Previous studies had shown that DNA methylation of
constitutive heterochromatin decreases in senescence and ag-
ing which is probably caused by downregulation of the DNA
methyltransferase DNMT1 (Wilson and Jones 1983; Young
2003; Zhang et al. 2008). In addition, potent inhibitors of
DNA methyltransferase such as 5-azacytidine (aza-C) led to
a reduction of DNA methylation in normal human fibroblasts
followed by premature senescence (Young 2001). However,
the genome-wide distribution of these changes remained un-
known. Using whole genome analyses, two recent papers now
demonstrate that large epigenetic changes occur in senescent
cells. De Cecco et al. used the formaldehyde-assisted isolation
of regulatory elements (FAIRE) method to map open chroma-
tin regions across the whole genome in replicative senescent
human diploid fibroblasts (De Cecco et al. 2013).
Interestingly, the authors observe an overall condensation of
chromatin in euchromatin gene-rich regions and a relaxation
of the late-replicating heterochromatin regions in senescent
cells (Fig. 4a). This latter event is associated with increased
transcription of retrotransposons as well as pericentromeric
satellite repeats, consistent with previous studies showing
transcription of satellites 2 and 3 as a result of decondensation
and demethylation of the satellite repeats in senescent cells
(Suzuki et al. 2002; Enukashvily et al. 2007). Remarkably,
hypomethylated satellite DNA present in immunodeficiency,
centromeric instability, and facial dismorphy (ICF) cells lo-
calized in large PML-NBs (Luciani 2006). Maybe satellite
repeats could also localize in the larger PML-NBs that have
been observed upon senescence (Pearson et al. 2000; Ferbeyre
et al. 2000), and this may explain their increased transcription
through an enhanced targeting of H3.3 to these regions. Of
note, increased transcription of retrotransposons and satellite
repeats occurred at late time points after senescence entry, thus
suggesting that these changes are likely a consequence rather
than a cause of epigenetic changes observed upon senescence
(De Cecco et al. 2013).
To what extent changes in DNAmethylation are implicated
in the senescence process has also been largely unexplored
until recently. Cruickshanks et al. now provide the first com-
prehensive analysis of DNAmethylation in senescent cells by
performing a whole-genome single-nucleotide bisulfite se-
quencing. They observe extensive changes in DNA methyla-
tion in senescent cells as compared to proliferating cells.
Senescent cells harbor widespread hypomethylation in late-
replicating, gene-poor regions, including pericentromeric sat-
ellites and LADs (Cruickshanks et al. 2013), consistent with
the “open conformation of these regions observed by FAIRE-
chip (De Cecco et al. 2013) and the enrichment in H3K4me3
in these large domains (Shah et al. 2013). This hypomethyla-
tion resulted in increased transcription of these regions, corre-
lating with the decreased expression of DNMT1 (De Cecco
et al. 2013; Cruickshanks et al. 2013). On the other hand, local
hypermethylation was observed at promoter-proximal re-
gions, flanking cytosine-phosphate-guanine (CpG) islands,
and this was associated with repression of cell cycle genes in
senescence (Cruickshanks et al. 2013) (Fig. 4b). Thus, these
results suggest that global changes in DNAmethylation might
be effectors in the senescence process, although they might
also be redundant with other senescence triggers and effectors
(for review, Kuilman et al. 2010).
Importantly, the global epigenetic events described above,
including derepression of retrotransposons, increased satellite
transcription, global DNA hypomethylation, and local hyper-
methylation at CpG islands, have been previously document-
ed in cancer cells (Belancio et al. 2010; Hansen et al. 2011;
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Berman et al. 2011; Jones and Jones 2012; Tilman et al. 2012).
Thus, it was hypothesized that these changes could prefigure
epigenetic cancer changes (Cruickshanks et al. 2013). First,
Cruickshanks et al. show that altered methylation states in
senescence (differentially methylation regions, DMRs) over-
lap with those described previously in cancer cells. While
replicative and OIS are barriers to cell transformation, these
data suggest that the premalignant senescent cells present
features of the cancer methylome. Second, this global epige-
netic landscape is retained in senescent cells that were forced
to bypass senescence by inactivation of p53 and pRb
(Cruickshanks et al. 2013). This suggests that if senescent
cells can escape the proliferative barrier, they may already
harbor an epigenetic landscape likely to promote genome
instability and cancer.
Potential functional roles of chromatin alterations
in senescent cells
Potential functions associated with chromatin reorganization
upon senescence
The stability of the growth arrest of senescent cells contributes
to the tumor suppressor function of cellular senescence, and it is
therefore crucial that senescent cells actively maintain a nondi-
viding state. Two mechanisms potentially ensure the irrevers-
ibility of the senescent state: first, the existence of mechanisms
that prevent cell cycle reentry in S-phase and in M-phase via
p53 and pRb pathways (for review, Funayama and Ishikawa
2007). In addition, it has been hypothesized that chromatin
reorganization contributes to the stability of the cell cycle arrest.
Indeed, SAHF contribute to the senescence-associated cell
cycle arrest in part by silencing proliferation-promoting genes,
such as cyclin A, through heterochromatinization (Narita et al.
2003; Zhang et al. 2007a). In addition, an alternative function
for SAHF was recently put forward: D’Adda di Fagagna and
colleagues showed that oncogene-induced SAHF formation
may protect premalignant cells from undergoing apoptosis by
limiting extensive DNA damage caused by replication stress to
sublethal levels (DiMicco et al. 2011). These findings led them
to suggest that there are two types of heterochromatin in
senescent cells: one that suppresses expression of cell cycle-
related genes and one that suppresses the DNA damage re-
sponse. Inactivation of ATM or p53 is sufficient to release
proliferation-promoting genes from heterochromatin-mediated
repression even though SAHF persisted (Di Micco et al. 2011).
Thus, SAHFmay not be sufficient to maintain the proliferation
arrest (Kosar et al. 2011).
It is still unclear to what extent the chromatin reorganiza-
tion plays a role in the tumor suppression function of senes-
cence in vivo. While it is well established that senescent cells
are present in vivo in several types of benign or premalignant
tumors but not in malignant tumors of mouse and human
tissues (Denchi et al. 2005; Braig et al. 2005; Chen et al.
2005; Collado et al. 2005; Michaloglou et al. 2005), one study
failed to detect SAHF in premalignant human tissues (Kosar
et al. 2011). However, other studies identified SAHF-like
alterations in the early stages of in vivo OIS (Denchi et al.
2005; Collado et al. 2005; Di Micco et al. 2011). In addition,
disruption of the Suv39h1 histone methyltransferase, that is
responsible for methylation of the H3K9me3 present in
SAHF, dramatically accelerates Ras-induced T cell lympho-
magenesis in a mouse model (Braig et al. 2005), thus impli-
cating these structures in the tumor-suppressing role of senes-
cence. Taken together, while it is clear that chromatin reorga-
nization plays a crucial role in the senescence state both
in vitro and in vivo, the specific contribution of SAHF in this
process still needs to be better defined.
Dynamics of histone incorporation in senescent cells
While senescent cells do not divide by definition and because
chromatin structure is inherently dynamic (Deal et al. 2010),
the question of how chromatin is maintained in the absence of
DNA replication has remained elusive. Using the SNAP tag
technique that allows dynamic labeling of preexisting or new
histone pools (Ray-Gallet et al. 2011; Bodor et al. 2012), we
addressed the question of the dynamic incorporation of his-
tone H3 variants in oncogene-induced senescent cells. We
showed that there is a de novo incorporation of new H3.3
histones in chromatin in senescent cells, in regions correlating
with the transcriptional activity of senescent cells (Corpet
et al. 2014). This suggests that replication-independent chro-
matin assembly is an important mode of histone replacement
in nondividing senescent cells, consistent with the accumula-
tion of H3.3 in aging human fibroblasts (Rogakou and Sekeri-
Pataryas 1999). Recent studies identifying driver H3.3 muta-
tions in pediatric glioblastomas (Schwartzentruber et al. 2012;
Wu et al. 2012; Khuong-Quang et al. 2012; Sturm et al. 2012)
or linking H3.3 incorporation with cellular memory (Ng and
Gurdon 2007) further underscore the physiological impor-
tance of H3.3 deposition for the maintenance of chromatin
structure and cellular phenotype. However, it remains to be
established to what extent H3.3 deposition is important for the
stability of the senescent phenotype. Since HIRA has been
implicated in transcription-coupled deposition of H3.3 (Ray-
Gallet et al. 2011), knockdown experiments of this particular
chaperone should address this question.
In contrast, new H3.1 is not incorporated in senescent cells,
consistent with its replication-coupled assembly mode.
However, H3.1 is accumulated in SAHF upon induction of
senescence (Corpet et al. 2014), possibly as a result of the high
condensation of chromatin in these regions. The mechanism
of H3.1 maintenance in SAHF, possibly over decades of
senescence, is unknown. Its specific chaperone CAF-1 is
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downregulated in senescence indicating other modes of main-
tenance (Corpet et al. 2010). The recently demonstrated
longevity of histone H3.1 (Toyama et al. 2013) might
provide a potential explanation. Thus, the senescent
state requires chromatin maintenance mechanisms that
are independent of DNA replication. It remains to be
determined if senescence-associated H3.1 and H3.3 dy-
namics is similar to that in terminally differentiated
postmitotic cells.
Conclusion
In this review, we summarized recent progress in understand-
ing the dynamics of chromatin conformation and epigenetic
marks in cellular senescence and discussed how they may act
as potential effectors of senescence. In particular, develop-
ment of techniques that allow genome-wide studies has been
instrumental for the analysis of the molecular alterations in the
epigenome of the senescent cells (Chandra et al. 2012; De
Cecco et al. 2013; Sadaie et al. 2013; Shah et al. 2013;
Cruickshanks et al. 2013). While the relative contribution of
local versus global chromatin changes in the senescence pro-
cess remains to be further deciphered, these recent studies
revealed major chromatin rearrangements induced by
LMNB1 loss and these have been shown to impact on the
gene expression profiles of senescent cells.
Besides, alterations in chromatin states changes in cell
metabolism also regulate senescence entry (Young et al.
2009; Weyemi et al. 2011; Jiang et al. 2013; Aird et al.
2013; Kaplon et al. 2013) (for review, Salama et al. 2014).
Because strong evidence now supports the idea of a physio-
logical role of senescence both in development (Muñoz-Espín
et al. 2013; Storer et al. 2013) and as an anticancer barrier (for
review, Collado and Serrano 2010) understanding the molec-
ular mechanisms of chromatin changes upon senescence
might open up new avenues to modulate this complex
phenotype in cancer therapy. In summary, all the find-
ings that we reviewed here indicate that dynamic alter-
ations of chromatin states are important for the senes-
cent phenotype on many different levels and are part of
a network of multiple effector pathways that contribute
to this heterogeneous phenotype.
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